ResearcherUniversity of OxfordActive in the last 2 years
Rachael J. M. Bashford-Rogers
Matched on ORCID iD 0000-0002-6838-0711; OpenAlex author ID A5032852377. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2021: 2 papers · 2022: none · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers
Papers 9
- In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surrounding microenvironment. Co-author DOI 10.1016/j.celrep.2025.116827↗
- Coordinated immune architecture underlies durable survival in pancreatic cancer Co-author DOI 10.64898/2026.04.29.721612↗
- Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms. Last author DOI 10.1038/s41467-024-55424-2↗
- Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validation of a clinical risk prediction model. Co-author DOI 10.1038/s41416-024-02693-9↗
- Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. Co-author DOI 10.7554/elife.92672↗
- Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells. Co-author DOI 10.1016/j.isci.2023.106324↗
- Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal adenocarcinoma (PDAC): a nested case-contr… Co-author DOI 10.1136/gutjnl-2021-326522↗
- Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the development and validation of a clinical p… Co-author DOI 10.1101/2021.12.22.21268161↗
- Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer. Co-author DOI 10.3390/cancers13081776↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shivan Sivakumar · 9 shared papers, 2021–2026 · strength 1.57
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Coordinated immune architecture underlies durable survival in pancreatic cancer DOI 10.64898/2026.04.29.721612↗
- Paper In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surro… DOI 10.1016/j.celrep.2025.116827↗
- Michael Loran Dustin · 4 shared papers, 2021–2026 · strength 0.65
- Paper Coordinated immune architecture underlies durable survival in pancreatic cancer DOI 10.64898/2026.04.29.721612↗
- Paper Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulat… DOI 10.1016/j.isci.2023.106324↗
- Paper Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell sel… DOI 10.1038/s41467-024-55424-2↗
- Lara Rosaline Heij · 4 shared papers, 2021–2026 · strength 0.63
- Paper In situ multi-modal characterization of pancreatic cancer reveals tumor cell identity as a defining factor of the surro… DOI 10.1016/j.celrep.2025.116827↗
- Paper Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulat… DOI 10.1016/j.isci.2023.106324↗
- Paper Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell sel… DOI 10.1038/s41467-024-55424-2↗
- Adam Enver Frampton · 3 shared papers, 2023–2026 · strength 0.54
- Paper Coordinated immune architecture underlies durable survival in pancreatic cancer DOI 10.64898/2026.04.29.721612↗
- Paper Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulat… DOI 10.1016/j.isci.2023.106324↗
- Paper Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell sel… DOI 10.1038/s41467-024-55424-2↗
- Ashley Kieran Clift · 3 shared papers, 2021–2024 · strength 0.54
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the de… DOI 10.1101/2021.12.22.21268161↗
- Carol A. C. Coupland · 3 shared papers, 2021–2024 · strength 0.54
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the de… DOI 10.1101/2021.12.22.21268161↗
- Julia Hippisley‐Cox · 3 shared papers, 2021–2024 · strength 0.54
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the de… DOI 10.1101/2021.12.22.21268161↗
- Pui San Tan · 3 shared papers, 2021–2024 · strength 0.54
- Paper Predicting the risk of pancreatic cancer in adults with new-onset diabetes: development and internal-external validatio… DOI 10.1038/s41416-024-02693-9↗
- Paper Temporality of body mass index, blood tests, comorbidities and medication use as early markers for pancreatic ductal ad… DOI 10.1136/gutjnl-2021-326522↗
- Paper Predicting risk of pancreatic cancer in individuals with new-onset type-2 diabetes in primary care: protocol for the de… DOI 10.1101/2021.12.22.21268161↗
- Ashwin Jainarayanan · 3 shared papers, 2021–2025 · strength 0.44
- Paper Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulat… DOI 10.1016/j.isci.2023.106324↗
- Paper Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell sel… DOI 10.1038/s41467-024-55424-2↗
- Paper Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer. DOI 10.3390/cancers13081776↗
- Shihong Wu · 2 shared papers, 2025–2026 · strength 0.37
- Anguraj Sadanandam · 1 shared paper, 2026 · strength 0.21
- Nabeel Merali · 1 shared paper, 2026 · strength 0.21
- Nicola E. Annels · 1 shared paper, 2026 · strength 0.21
- Tarak Agrebi Moumni Chouari · 1 shared paper, 2026 · strength 0.21
- Elisa Giovannetti · 1 shared paper, 2026 · strength 0.21
- Alex Nicolas Gordon-Weeks · 1 shared paper, 2026 · strength 0.21
- Anna Lyubetskaya · 1 shared paper, 2026 · strength 0.19
- Eugene Drokhlyansky · 1 shared paper, 2026 · strength 0.19
- Simone Lanfredini · 1 shared paper, 2024 · strength 0.18
- Simei Go · 1 shared paper, 2024 · strength 0.18
- Somnath Mukherjee · 1 shared paper, 2024 · strength 0.18
- Keaton Ian Jones · 1 shared paper, 2024 · strength 0.18
- Jennifer P. Morton · 1 shared paper, 2024 · strength 0.18
- Eric E. O’Neill · 1 shared paper, 2024 · strength 0.18
- Samarth Hegde · 1 shared paper, 2025 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.